Home Tags Bharat Biotech

Tag: Bharat Biotech

Made-in-India intranasal Covid vaccine to be launched on R-Day
COVID_19

First ‘Made-in-India’ intranasal Covid vaccine to be launched by Bharat Biotech...

PGurus Newsdesk - 1
Bharat Biotech to launch intranasal Coronavirus vaccine 'iNCOVACC' on Republic Day Bharat Biotech will launch its intranasal COVID-19 vaccine 'iNCOVACC' on January 26, the company's...
The nasal vaccine has been approved for those aged above 18 years. The vaccine will be available in private hospitals for a booster dose in the initial phase
COVID_19

Bharat Biotech’s needle-free intranasal Covid vaccine approved as booster dose

PGurus Newsdesk - 2
The intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from today The Centre on Friday approved Bharat Biotech's needle-free intranasal Covid vaccine...
Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine Covaxin
COVID_19

Japan includes India’s Covaxin in the list of recognized vaccines to...

PGurus Newsdesk - 0
Japan recognizes India's Covaxin with effect from 10 April Japan recognizes India's COVID-19 vaccine Covaxin manufactured by Bharat Biotech with effect from 10 April to...
People above 18 years of age, with a vaccination history of more than five months but less than seven months are eligible to participate in the phase 3 trial
COVID_19

AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from...

PGurus Newsdesk - 0
AIIMS Delhi to start clinical trials of Bharat Biotech’s intranasal booster vaccine All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials...
With more than 200 million doses having been administered to adults outside the US, Covaxin is currently authorised under emergency use in 20 countries
COVID_19

Covaxin to be evaluated as Covid vaccine candidate in the US:...

PGurus Newsdesk - 0
US FDA lifts clinical hold on Bharat Biotech's Covid vaccine Covaxin On Saturday Bharat Biotech said that its Covaxin will be evaluated as a COVID-19...
As against injectable vaccines, intranasal vaccine is claimed to be easy to administer during mass inoculation campaigns
COVID_19

Bharat Biotech gets a nod from DGCI for phase 3 trials...

PGurus Newsdesk - 0
Bharat Biotech gets SEC approval for phase 3 clinical trials of nasal vaccine as a booster shot As India stares at the third wave of...
Covaxin is now the second vaccine cleared for use for children in India
COVID_19

Covaxin gets a nod for emergency use for 12-18 age group...

PGurus Newsdesk - 0
Covaxin gets emergency use approval for children aged between 12-18 years As Omicron cases surges in India, the Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on...
Increasing the Covaxin shelf life helps reduce the carbon footprint, says the company
Health

Shelf life of Covaxin extended to 12 months from the date...

Team PGurus - 1
Extended shelf-life for Covaxin helps lessen vaccine wastage The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's...
COVID-19 booster shot should be ideally taken 6 months after the 2nd dose says Bharat Biotech's Founder and MD
COVID_19

6 months post second COVID-19 vaccine dose perfect time for booster...

PGurus Newsdesk - 0
BB's Krishna Ella proposes a booster dose after six months of the second dose Bharat Biotech Chairman and Managing Director Krishna Ella said that the ideal time for a...
Covaxin | The Emergency Use Listing nod to Bharat Biotech's Covaxin, which was found to have 77.8 percent efficacy against COVID-19 virus
Lifestyle

Finally!!! WHO approves India’s indigenous vaccine Covaxin by Bharat Biotech

PGurus Newsdesk - 1
Covaxin gets WHO approval for EUL India's first indigenous COVID-19 vaccine Covaxin got its long-due approval from the World Health Organisation (WHO) on Wednesday. The WHO's...
12Page 1 of 2

BOOKS

Dailymotion Facebook Instagram Paypal Soundcloud Telegram Twitter Youtube
© 2021 PGurus | All rights reserved.
error: Content is protected !!